Latest News

News

Zika virus protection patch shows promise in recent study

News shared by the University of Queensland (UQ) in December 2023 details explains how a paper in Molecular...

“Let communities lead!” UNAIDS report, World AIDS Day 2023

In 1988 the first World AIDs Day was launched under the theme “A world united against AIDS”; in...

ADDomer vaccine platform has disease-fighting potential

In research shared by the University of Bristol in November 2023, a team demonstrate the validity of nature-inspired...

Immunotherapy innovation: myNEO Therapeutics’ Cedric Bogaert

Last month we were delighted to speak to so many of our fantastic speakers and exhibitors and here...

Merck (MSD) shares STRIDE-3 pneumococcal vaccine insights

In November 2023 Merck, which is known as MSD outside the US and Canada, announced results from a...

CEPI, IVI and Gambia’s MRC launch Preparedness Programme

In November 2023 CEPI, IVI, and Gambia’s Medical Research Council Unit The Gambia (MRCG) announced the launch of...

Canada’s VIDO awarded IDIQ contract by US NIAID

In November 2023 the University of Saskatchewan’s Vaccine and Infectious Disease Organisation (VIDO) announced that it has been...

Back to VacTrack: digital solutions with Gabriella and Emily

With the World Vaccine Congress West Coast kicking off today we are pleased to share another exclusive interview...

UKHSA confirms human case of influenza A(H1N2)v

In November 2023 the UKHSA stated that a single human case of influenza A(H1N2)v has been detected in...

Re-engineered clamp platform produces safe vaccine

The University of Queensland (UQ) announced in November 2023 that its “re-engineered clamp platform” has produced a vaccine...

Security and self-reliance: Africa CDC’s Akhona Tshangela

Our next interview in the European Congress series is with Africa CDC's Akhona Tshangela, who joined us at...

WHO requests information: China’s pneumonia in children

WHO shared a statement in November 2023 that reveals an “official request” to China for “detailed information” on...

Malaria vaccines to Africa “herald final steps”

A joint news release from WHO, UNICEF, and Gavi in November 2023 states that shipments of the first...

SK bioscience and Hilleman join on Zaire Ebola efforts

In November 2023 SK bioscience and Hilleman Laboratories shared that they have entered into a development licensing agreement...

Targeted immune responses: Belyntic’s Andreas Regnery

Our next Congress Conversation from the event in Barcelona last month is with Andreas Regnery, who represented Belyntic...

Mpox vaccine prioritisation study: who and how many?

In a paper for Vaccine in November 2023 an international group of authors comment on the “unjust” distribution...

Unpacking America’s “Vaccine Wars” with Professor Mark Navin

With the Congress only days away we are delighted to share another exclusive Congress Conversation ahead of the...

BMJ investigates RSV informed consent concerns

In a feature for The BMJ in November 2023 Hristio Boytchev reports on concern raised by “some experts”...

Micron secures Gates funding for needle-free vaccines

In November 2023 Micron Biomedical announced that the Bill and Melinda Gates Foundation has committed a $23.6 million...

Vaccines Europe explores vaccination strategies for AMR

In a white paper shared in November, Vaccines Europe explores how vaccination can be a “valuable tool” to...

Technology for “actionable insights”: Dr Nicolas Gaudenzio

Next up in our exciting Congress Conversations series is an interview with Genoskin's Dr Nicolas Gaudenzio. He joined...

Dynamics of nAbs: progress towards HIV-1 vaccine in research

A team of researchers shared in November 2023 that their study, published in Nature Medicine, has provided insight...

Study: how might a Strep A vaccine reduce antibiotic use?

As the threat presented by antimicrobial resistance (AMR) grows globally, the pressure is mounting on the vaccine community...

“We know what works”: the “last mile” with Dr Angus Thomson

With the Congress behind us we are able to reflect on the key themes and discussions that took...

UK JCVI recommends routine childhood chickenpox vaccination

In November 2023 the UK’s Joint Committee on Vaccination and Immunisation (JCVI) announced that it was recommending a...

NHS testing finds thousands of bloodborne virus cases

In November 2023 the UKHSA and University of Bristol shared a report that reveals the results of an...

WHO commissions Vaccine Value Profiles for endemic pathogens

In what WHO is describing as a “significant stride towards facilitating and informing priorities in global vaccine development”...

UK JCVI encourages routine vaccination: gonorrhoea and mpox

In November 2023 the UK’s Joint Committee on Vaccination and Immunisation issued advice to the government on a...

FDA approves Valneva’s world-first chikungunya vaccine

In November 2023 Valneva announced that the US FDA has approved its single-dose, live-attenuated vaccine for the prevention...

Childhood vaccine refusal study: what is to be done?

In a study published in BMC Medical Ethics the authors present a systematic review of normative arguments made...

Vaccines for everyone: study investigates HPV strategies

Research published in Cell Host & Microbe in November 2023 reaches a “somewhat provocative conclusion” that HPV vaccination...

BioCina and CPN Vaccines expand Gamma-PN partnership

In November 2023 BioCina and GPN Vaccines announced that they are expanding their partnership to develop GPN’s proprietary...

WHO shares Tuberculosis Report 2023: more effort needed

In November 2023 the WHO shared the Global Tuberculosis Report 2023, a “comprehensive and up-to-date assessment” on the...

EU and Africa CDC share agreement on access and manufacture

In October 2023 at the Global Gateway Forum, held in Brussels, the EU Commission signed €500 million for...

MSD Animal Health pursues cattle health success

In October 2023 MSD Animal Health announced that the European Medicines Agency Committee for Veterinary Medicinal Products (CVMP)...

Nasal COVID-19 vaccine shows promise in animals

Researchers from the University of Maryland shared in November 2023 that they have made progress in developing a...

4 vaccine hubs get funding: UK Vaccine Network

In November 2023 the UK’s Minister for Health and Secondary Care, Will Quince, announced at the Association of...

CEPI and University of Oxford: vaccines against Junín virus

In November 2023 CEPI and the University of Oxford announced a new project to “initiate the early development...

All for One Health: marking One Health Day 2023

Friday 3rd November 2023 is the 8th annual One Health Day, observed internationally to “raise global awareness” of...

Study sheds light on vaccine-related blood clotting

Researchers from the University of Birmingham shared in October 2023 that a paper in Blood identifies how blood...

Partnership to harness technology against malaria hurdles

In October 2023 the European Vaccine Initiative (EVI) announced that it will be coordinating a new partnership to...

AI identifies possible vaccine candidates for gonorrhoea

Research published in mBio in October 2023 shows that artificial intelligence (AI) could be used to effectively identify...

Health preparedness is “fragile” warns GPMB 2023 report

A report shared by the Global Preparedness Monitoring Board (GPMB) in 2023 offers a “warning” that the “fragile...

A world in polycrisis: disease in AXA’s Future Risks Report

In October 2023 AXA published the 10th edition of its Future Risks Report, a study that “measures and...

CEPI and Moderna announce mRNA strategic partnership

In October 2023 CEPI and Moderna announced a strategic partnership to “harness Moderna’s mRNA platform” for vaccine development...

Tripartite recommendations on oral rabies vaccinations

In October 2023 the Tripartite organisations, issued an update on oral vaccination of dogs against rabies: recommendations for...

Human Immune Project shares 5-year ‘Scientific Plan’

Human Immune Project (HIP), a global nonprofit organisation dedicated to “decoding and modelling the immune system”, shared a...

Global journals publish climate call: one indivisible crisis

200 health journals published an editorial demanding recognition that “climate change and biodiversity loss” are “one indivisible crisis”...

AI tool EVEscape could predict viral variation emergence

An artificial intelligence (AI) tool developed by a team from the University of Oxford and Harvard Medical School...

UKRI funds Oxford study to investigate human immunity

In October 2023 the University of Oxford’s Oxford Vaccine Group announced funding from the Medical Research Council within...

Make polio history: World Polio Day, 24th October 2023

On 24th October 2023 global health leaders, advocates, and communities highlight efforts to end poliomyelitis (polio). Each year...

Translating science into survival: BioNTech’s Dr Ruben Rizzi

With our Congress in Barcelona mere days away we are glad to share another of our exclusive speaker...

Polio partnership to support immunisation and health systems

In October 2023 the European Commission, the European Investment Bank, and the Bill & Melinda Gates Foundation announced...

Delivering vaccines at “lightspeed”: Pfizer’s Bill Falstich

The World Vaccine Congress in Barcelona is so close (less than a week now!) and we are delighted...

Vaccine start-ups return to the World Vaccine Congress!

Our World Vaccine Congress in Barcelona is now next week and our start-up zone has reached capacity! This...

Angany announces start of cat allergy vaccine trial

In October 2023 Franco-Canadian Angany announced that it has received a Notice of Acceptance from the UK’s Medicines...

UKRI announces Tackling Infections funding for projects

In October 2023 the UK Research and Innovation (UKRI) announced £25 million funding to three projects “designed to...

Driving regulatory evolution with EMA’s Dr Marco Cavaleri

With just a week to go until the Congress in Barcelona we are delighted that another of our...

Aberdeen team moves to understand adverse reactions

The University of Aberdeen announced in October 2023 that a team of scientists has “taken an important step”...

Gates announces investments for LMIC mRNA capacity

At the 2023 Grand Challenges Annual Meeting in October 2023 Bill Gates announced new Bill and Melinda Gates...

GSK and Zhifei agree partnership for Shingrix in China

In October 2023 GSK announced that it has secured an exclusive agreement with Chongqing Zhifei Biological Products (Zhifei)...

Experimental vaccine turns immune system to “Hulk”

Research published in Science Translational Medicine and shared by the University of Southern California in October 2023 demonstrates...

Experts call for “gender-responsive” Pandemic Accord

A commentary in The Lancet in October 2023 calls for a “gender-responsive” Pandemic Accord to secure a “healthier...

“Preparedness far outweighs response” says Dr Amy Shurtleff

With less than a fortnight to go until the Congress in Barcelona we are thrilled to share another...

Sanofi and Janssen announce E. coli vaccine collaboration

In October 2023 Sanofi announced that it has joined forces with Janssen Pharmaceuticals to develop and commercialise the...

A crisis management case study: Uganda’s 2022 Ebola outbreak

In a paper published in the Journal of Public Health in Africa in September 2023 a team of...

WHO issues update on Nipah virus outbreak in India

In October 2023 the WHO issued a statement with updates about the outbreak of Nipah virus that was...

Vaccine start-ups return to the World Vaccine Congress!

We are now down to just weeks to the  World Vaccine Congress in Barcelona, and our start-up zone...

Women, power, and cancer: an investigative Lancet Commission

The “nexus of women, power, and cancer” is the subject of investigation by The Lancet Commission in September...

VLP based vaccines lower LDL cholesterol in study

A paper in npj vaccines presents the results of a study assessing the efficacy of VLP-based vaccines displaying...

UKHSA and ONS plan new Winter COVID-19 Infection Study

The UKHSA and Office of National Statistics (ONS) announced in October 2023 that they are launching a “vital...

WHO recommends Oxford’s malaria vaccine for use

In October 2023 the University of Oxford announced that the WHO has recommended its malaria vaccine for the...

Nobel celebrations for mRNA scientists Karikó and Weissman

On 2nd October 2023 the Nobel Prize in Physiology or Medicine 2023 was announced as jointly awarded to...

WHO: southern hemisphere flu vaccine recommendations

In September 2023 the WHO announced recommendations for the viral composition of influenza vaccines for the 2024 influenza...

BactiVac announces government funding: vaccines vs AMR

In September 2023 the University of Birmingham shared that the Bacterial Vaccines Network (BactiVac) was awarded £1.4 million...

Gavi’s 2022 progress report: rebounds and challenges

In September 2023 Gavi announced the publication of its 2022 Annual Progress Report, which presents insights into a...

CEPI and Global Affairs Canada collaborate on biosecurity

CEPI announced a “renewed collaboration” with Global Affairs Canada, comprising CAD 1 million in funding to “accelerate the...

Report: investigating vaccine manufacturing in Africa

Before and during the COVID-19 pandemic that Africa’s demand for vaccines exceeds its local supply: 99% of vaccines...

COVID-19 vaccines and unexpected vaginal bleeding

Although insufficient attention has been directed towards the effects of vaccination on menstrual experiences, a study published in...

Gritstone bio awarded BARDA contract for COVID-19 study

In September 2023 Gritstone bio announced that is has been awarded a contract by BARDA to conduct a...

Revital gets Pre-Qualification: early activation AD syringe

In September 2023 Revital Healthcare announced a “historic milestone in African manufacturing excellence”. The company was awarded Pre-Qualification...

Genomic surveillance strategies: WHO’s step-by-step guide

WHO shared Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and...

Vaccine start-ups return to the World Vaccine Congress!

In the last few weeks before the World Vaccine Congress in Barcelona, our start-up zone is reaching capacity! This...

Cambridge shares further antigen technology success

The University of Cambridge announced in September 2023 that a vaccine antigen technology developed in collaboration with spin-out...

UKHSA and CSL Seqirus partnership: flu pandemic preparation

In September the UKHSA announced an agreed deal for “millions of life-saving vaccines” has been signed with CSL...

“A New Species of Trouble”: pandemic preparation in Africa

Pandemic Centre at Brown University School of Public Health publication emphasises the importance of “identification, attribution, and consequence...

Tuberculosis goals: leaders reaffirm “collective commitment”

At the United Nations General Assembly high-level meeting on tuberculosis world leaders approved a political declaration reaffirming their...

WHO’s 2022 statistics reveal global cholera surge

Data from the WHO published in September 2023 offer an insight into the extent of cholera surges across...

UK government announces health security package at UNGA

The UK’s International Development Minister Andrew Mitchell and Health Minister Will Quince announced investments in “ground-breaking research and...

Vir Biotechnology begins Phase I HIV vaccine trial

In September 2023 Vir Biotechnology announced that the first participant in a Phase I trial has been dosed...

Google’s DeepMind shares catalogue of disease insights

In September 2023 Google’s AI organisation, DeepMind, released a catalogue of genetic mutations intended to accelerate disease diagnosis...

WHO “welcomes” UNGA landmark pandemic declaration

At the UNGA 78th session in September 2023 a “landmark declaration” was adopted on pandemic prevention, preparedness, and...

Bio Farma and CEPI forge 10-year vaccine partnership

In September 2023 CEPI and Bio Farmer announced the agreement of a 10-year partnership to “boost rapid manufacturing...

Vaccine start-ups return to the World Vaccine Congress!

With less than a month until the World Vaccine Congress in Barcelona, our start-up zone is continuing to grow!...

Report: how can the EU improve its vaccine industry appeal?

A study carried out by Charles River Associates (CRA) for Vaccines Europe (VE) in June 2023 investigates the...

Oxford: PSI begins ChAdOx1 MERS vaccine trial

In September 2023 the University of Oxford’s Pandemic Sciences Institute (PSI) announced that a Phase I clinical trial...

BioNTech and CEPI announce mRNA mpox partnership

In September 2023 BioNTech and CEPI announced a strategic partnership to advance mRNA-based vaccine candidates for the prevention...

Bluetongue virus: serotype 3 confirmed on Dutch sheep farms

An update from Wageningen Bioveterinary Research in September 2023 shared that the European reference laboratory in Madrid has...

High alert: confirmed outbreak of Nipah in India

India announces containment measures to control the spread of Nipah, detected in the southern state of Kerala, attention...

CEPI and UC Davis partner on Rift Valley fever virus vaccine

In September 2023 CEPI and the University of California, Davis (UC Davis) announced a partnership to advance human...

UKHSA expands SIREN study on respiratory pathogens

In September 2023 the UKHSA announced that the flagship SIREN study is “entering a new phase” of surveillance...

WHO urges health commitment at 78th UN General Assembly

Next week, from 18th to 26th September 2023, the United Nations General Assembly (UNGA) will take place in...

Oxford begins first-in-human trials for CCHF vaccine

In September 2023 the Oxford Vaccine Group (OVG) and Pandemic Sciences Institute (PSI) of the University of Oxford...

Vaccine start-ups return to the World Vaccine Congress!

With just over a month until the World Vaccine Congress in Barcelona, our start-up zone is continuing to grow!...

Off-the-shelf lung cancer vaccine makes “major” progress

In September 2023 Ose Immunotherapeutics announced the publication of new data supporting its cancer vaccine, Tedopi, in HLA-A2...

An mRNA vaccine offers “promise” against Lassa virus

A paper published in Nature Communications in September 2023 presents the results of an investigation into the effects...

Inverse vaccine could stop autoimmune reactions

A vaccine developed by researchers at the University of Chicago’s PME has demonstrated in the lab that it...

Elevating the potential of cancer vaccines: Dr Kyle Holen

As we find ourselves in September and ever closer to the Congress in Barcelona next month, our interview...

Research into intranasal RNA COVID-19 vaccines at MIT

A team at the Massachusetts Institute of Technology (MIT) is working on COVID-19 RNA vaccine optimisation to try...

IVI and CEPI announce renewed vaccine collaboration

In September 2023 the Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) announced a...

Changes at molecular level: vaccines against leishmaniasis

Researchers at Ohio State University offered an insight into their work against leishmaniasis in August 2023. Phase I...

Vaccine start-ups return to the World Vaccine Congress

Getting closer to the World Vaccine Congress in Barcelona this October, our start-up zone is continuing to grow! We are...

England to bring forward autumn vaccination programmes

The UK government announced in August 2023 that the autumn flu and COVID-19 vaccine programmes will start “earlier...

Microwave freeze-drying technology: is it rocket science?

A lot of attention has been directed towards vaccine stability as the COVID-19 pandemic highlighted the weaknesses of...

Partners approach human trials for drug overdose vaccines

A partnership involving a team at the University of Montana, funded by NIH, suggests that it is “nearing...

CEPI partners with Oxford, funding vaccines for Disease X

In August 2023 CEPI announced a commitment of up to $80 million to support the design, manufacture, and...

Chikungunya “invisibility” insights may accelerate vaccines

Albert Einstein College of Medicine announced in August that their publication in Nature Microbiology could help vaccine development...

C-TAP and MPP announce new licensing agreements

In August 2023 WHO announced that the COVID-19 Technology Access Pool (C-TAP) has announced three new licensing agreements...

GC Biopharma and EuBiologics join forces on cholera

A business agreement signed between GC Biopharma and EuBiologics in August 2023 allows the companies to jointly produce...

Wellcome supports Vaxxas with HD-MAP technology

In August 2023 Vaxxas announced that Wellcome has awarded the company £2.84 million to conduct IND-enabling studies and...

“Tremendously exciting” results in malaria combination trial

In August 2023 researchers in an international partnership shared the results of a Phase III study in The...

UKHSA meningitis warning: 1 in 8 students unprotected

In August 2023 as the new academic year looms, the UKHSA and leading meningitis charities are “urging” students...

Project NextGen awarded HHS funding against COVID-19

The US Department of Health and Human Services (HHS) announced in August 2023 that it awarded more than...

Misled America: KFF study tracks vaccine misinformation

In August 2023 KFF shared the results of its Health Misinformation Tracking Poll Pilot as part of a...

CARsgen and Moderna unite to tackle Claudin18.2

A collaboration between Chinese company CARsgen and Texas-based Moderna was announced by the former in August 2023. The...

Vaccine start-ups return to the World Vaccine Congress!

With under two months until our World Vaccine Congress in Barcelona this October, our start-up zone is continuing...

Pfizer’s maternal RSV vaccine gets FDA approval

In August 2023 Pfizer announced that the US FDA has approved its vaccine against RSV in infants through...

UK announces £210 million AMR investment from aid budget

The UK Department of Health and Social Care announced that it was supporting “laboratories”, disease surveillance, and a...

Bovine TB: cattle pathway planning already underway

Farmers Weekly reported on discussions to develop a pathway for approval of the export of cattle vaccinated with...

Patient advocate by choice: Solve M.E.’s Oved Amitay

In this post we are thrilled to share a pre-event conversation with Solve M.E.'s President and CEO Oved...

Moderna’s updated COVID-19 jab fit for variants

In a statement released in August 2023 Moderna announced that preliminary clinical trial data “confirm” that the updated...

The threat of the unknown: what is “Disease X”?

In August 2023 the announcement of the newly unveiled Vaccine Development and Evaluation Centre in the UK provoked...

Vaccine start-ups return to the World Vaccine Congress!

We are inching ever closer to World Vaccine Congress in Barcelona this October, and our start-up zone is still growing!...

International partnership targets parasitic worms in sheep

Moredun Research Institute announced that it is leading an international partnership with the University of Glasgow and the...

Gritstone and Genevant announce vaccine agreement

In August 2023 Gritstone bio and Genevant Sciences announced an agreement through which Gritstone will be able to...

“Eris” variant more infectious: are there vaccines?

The EG.5 variant of SARS-CoV-2, identified in February 2023, has been classed as a “variant of interest (VOI)...

Study: how effective are seasonal flu vaccines?

A study in Vaccines against Influenza virus presents a systematic review and meta-analysis of RCTs and TNDs to...

EBV vaccine candidate makes progress in study

In a study published in Nature Communications in August 2023 presents early findings for a “cutting-edge” vaccine candidate...

Gavi leadership: Berkley passes the baton to Marlow

2nd August 2023, Dr Seth Berkley’s tenure as CEO of Gavi came to an end after 12 years...

UK’s COVID-19 autumn booster groups announced

In August 2023 the UKHSA shared an announcement from the Joint Committee on Vaccination and Immunisation (JCVI) regarding...

Vaccine start-ups return to the World Vaccine Congress!

Another week closer to World Vaccine Congress in Barcelona this October, and our start-up zone is expanding all the time! This week...

CEPI and Gennova collaborate on saRNA against Disease X

In August 2023 CEPI and Gennova Biopharmaceuticals Ltd announced a funding agreement of up to $3.6 million to...

UK’s Vaccine Development and Evaluation Centre opens

In August 2023 the UKHSA announced the opening of its “world-leading” Vaccine Development and Evaluation Centre in the...

Economist Impact launches Immunisation Readiness Index

Economist Impact’s The Vaccine Ecosystem launched the Immunisation Readiness Index, which measures the enabling environment for immunisation...

AAHI awarded millions for chikungunya vaccine pursuit

In August 2023 the Access to Advanced Health Institute (AAHI) announced that it had received an $18 million...

Vaccine start-ups return to the World Vaccine Congress!

With just over two months left until the World Vaccine Congress in Barcelona this October our start-up zone...

CDC’s Dr Cohen on gaining back America’s trust

Just weeks into her new role as Director of the US CDC, Dr Mandy Cohen has been busy...

EMA works towards better emergency clinical trials

In a report published by the European Medicines Agency in July 2023 the lessons from the COVID-19 and...

Nationwide survey finds Nipah virus in Indian bats

In July 2023 The Indian Express reported that the Pune-based ICMR-NIV nationwide survey had found evidence of Nipah...

Vaccine combinations against bladder cancer: IO Biotech

IO Biotech announced that the University of California Davis Comprehensive Cancer Centre has dosed the first patient in...

Religion and vaccines: a study in religious scepticism

An article in Vaccine: X in August 2023 acknowledges that previous research has identified religion as one of...

Targeting inflamed brain cells to reduce Alzheimer’s

A team from Japan’s Juntendo University suggest that their latest vaccine, “SAGP”, may revolutionise treatment of Alzheimer’s disease...

National Sheep Association raises vaccine concerns

In July 2023, just days after we reported on a concerning lack of EAE vaccines in the UK...

World Hepatitis Day 2023: “We’re not waiting”

Under the call to action “We’re not waiting”, World Hepatitis Day takes place on 28th July 2023. This...

Stressed? It might affect your vaccine response, says study

In research published in Brain, Behaviour, and Immunity in July 2023, a group from Tel Aviv University found...

UK risks losing top vaccination status, warn MPs

MPs in the UK have warned that the country risks losing its place as a global leader in...

EAE vaccine supply delays concern sheep farmers

In July 2023 Farmers Guide reported that delays in the supply of a vaccine for EAE (enzootic abortion...

Merck and Moderna begin Phase III melanoma trial

Merck and Moderna announced the initiation of a Phase III clinical trial evaluating V940 (mRNA-4157) in combination with...

Vaccine start-ups return to the World Vaccine Congress!

As we get closer to the World Vaccine Congress in Barcelona this October our start-up zone is growing...

“Unusual increase” in GBS cases in Peru causes alert

WHO reported in July 2023 that the National Centre for Epidemiology, Prevention, and Disease Control (CDC) of Peru...

UKHSA establishes 3-year health threat strategy

In July 2023 the UK Health Security Agency (UKHSA) announced a new strategy, outlining its “vision and goals”...

New study models effect of vaccines against AMR

A study in BMJ Global Health in July 2023 uses a static proportional impact model to explore the...

IQVIA report: COVID-19 affected adult immunisations

A report by IQVIA Institute for Human Data Science, in collaboration with GSK and the Global Coalition on...

Vaccine adjuvants: problems and prospects in review

A review in July 2023 describes adjuvants as “indispensable components of vaccines” that are widely used but not...

Canada prepares for animal FMD with vaccine bank

After a meeting of the Federal, Provincial, and Territorial (FPT) Ministers of Agriculture in Canada, Ministers confirmed their...

US DoD awards VitriVax 5-year vaccine contract

In July 2023 VitriVax announced that it had been awarded a $29 million contract over 5 years from...

Continued progress for Vaxxinity against Parkinson’s

Less than a month since we reported Vaxxinity’s “promising” results in a trial of UB-312, the company has...

Pfizer’s maternal GBS6 may offer “meaningful” protection

Pfizer announced data from a Phase II study investigating its hexavalent capsular polysaccharide (CPS) conjugate Group B Streptococcus...

Vaccines are the “future” in cancer, says Dr Pravin Kaumaya

During the Congress last month we were pleased to meet Dr Pravin Kaumaya for a conversation about the...

New partnership to strengthen Africa’s health security

Africa CDC, WHO, and the Robert Koch Institute (RKI) launched a Health Security Partnership intended to strengthen disease...

Blue Water preclinical progress on mpox vaccine

Blue Water Biotech announced preliminary preclinical data in support of the use of a norovirus shell and protrusion...

AI to accelerate Disease X preparation and prevention

In a partnership announced in July 2023, CEPI and the Houston Methodist Research Institute (HMRI) will combine cutting-edge...

UNAIDS: ‘The Path that Ends Aids’ report released

In July 2023 UNAIDS released a report outlining a “clear path” to end AIDS and prepare for and...

Building back childhood immunisations after COVID-19

Data from WHO and UNICEF, shared in July 2023, suggest that fewer children missed routine vaccinations in 2022...

Dengue during pregnancy poses health risks to newborns

Although dengue, a viral infection transmitted through mosquito bites, threatens the health of “about half of the world’s...

UKHSA measles modelling shows London is at risk

Data from the UKHSA in July 2023 suggests a “steady rise” in measles cases in the UK throughout...

HHS to COVID-19 vaccine manufacturers: be “reasonable”

A letter from the US Secretary of Health and Human Services (HHS) in July 2023 to COVID-19 vaccine...

What do Africa CDC’s appointments mean for immunisation?

Africa CDC, the “autonomous public health institution of the African Union” (AU) announced in July 2023 that a...

PATH and SIIPL’s MenFive vaccine prequalified by WHO

Serum Institute of India (SIIPL) and PATH announced that the first conjugate vaccine against the five predominant causes...

Vaccine start-ups return to the World Vaccine Congress!

As we gear up for October’s World Vaccine Congress in Europe, we are delighted to see our start-up zone...

WHO warns of “ongoing risks” to humans from bird flu

WHO, Food and Agriculture Organisation (FAO), and the World Organisation for Animal Health (WOAH) united in a statement...

HIV vaccine trial shows “encouraging” early results

In July 2023 it was announced that preliminary analysis of vaccine trial results demonstrates the induction of “high...

Long COVID paper recognises several “unknowns”

In a paper in Nature reviews immunology in July 2023 a group of scientists investigate the “immunology” long...

WEF calls for “ambitious investment” in childhood vaccines

In an article for the World Economic Forum in July 2023 the importance of investment in childhood vaccines...

Reaching 2030 rabies goals requires vaccination

The World Organisation for Animal Health reminds us that rabies continues to kill around 59,000 people a year...

Conspiracies complicate childhood COVID-19 vaccinations

In a study published in Frontiers in Psychology researchers examine the link between conspiracy mindsets and uptake of...

Enterovirus cases in newborns causing concern in Europe

WHO reported in July 2023 that Member States within the European Region had notified the organisation of cases...

FIGO advocates for sustainable vaccination programmes

In July 2023 the International Federation of Gynaecology and Obstetrics (FIGO) published a supplement in the International Journal...

Sanofi sets sights on Saudi drugmakers Lifera and Arabio

In July 2023 it was announced that Sanofi had signed a Memorandum of Understanding (MoU) with Lifer and...

Moderna deal to bring China into the mRNA era

In July 2023 it was announced that Moderna had established an agreement with China to develop mRNA products...

UK government and BioNTech join forces on cancer trials

Following the signing of a memorandum between the UK government and BioNTech in January 2023, an agreement has...

Gavi announces malaria vaccine for 12 African countries

In a collaboration 12 countries across different regions in Africa are expected to receive a total of 18...

Farmers want government-led TB vaccination strategies

In a Defra-commissioned study published in VetRecord researchers investigated the attitudes of farmers to different vaccination approaches to...

UK secondary school pupils eligible for flu spray this year

In an update from the UK government in July 2023 over 3 million secondary school pupils will be...

FVVA framework guides vaccine value assessments

A paper in BMC Medicine presents an apparent solution to the economic obstacles to the development and use...

Pandemic preparedness: EU Commission strikes vaccine deals

At the end of June 2023 reports circulated that the EU Commission was preparing deals in anticipation of...

Data sharing key to tackling animal influenza, says OFFLU

As animal influenza continues to cause concern across the world, OFFLU has shared a 2022 report to showcase...

Is a new tuberculosis vaccine on the horizon?

In June 2023 Wellcome and the Bill and Melinda Gates Foundation announced funding to advance a tuberculosis (TB)...

Vaccine start-ups return to the World Vaccine Congress!

As we gear up for October’s World Vaccine Congress in Europe, we are delighted to see our start-up...

Zoonotic risk: UK bat screening finds coronaviruses

In a Nature Communications article in June 2023 a group of European-based researchers present results of screening for...

How did a vaccine mandate affect English care homes?

The contentious introduction of a vaccine mandate for staff in elderly care homes in England in 2021 was...

Study: immune cell age affects vaccination response

An article in Nature Communications in June 2023 presents research into age-associated B cells (ABCs) and how they...

Review of vaccine hesitancy in pregnancy finds continuum

A narrative review of vaccine hesitancy in pregnant women concludes that “hesitancy is dynamic”, and people “do not...

CEPI to provide funding for RVAC’s mRNA platform technology

CEPI announced a new partnership agreement to “advance and accelerate” RVAC’s manufacturing process for next-generation mRNA vaccine platform...

Vaxxinity announces positive Parkinson’s trial results

In June 2023 Vaxxinity announced positive results from Part B of the Phase I clinical trial of UB-312...

WHO project strengthened African health and vaccine systems

The WHO reported that a project from 2022 helped health systems become more resilient, arming them against epidemics...

GSK granted Fast Track designation for gonorrhoea vaccine

In June 2023 GSK announced that the US FDA has granted fast track designation for its Neisseria gonorrhoeae...

CEPI issues call for betacoronavirus challenge studies

CEPI issued a Call for Proposals for research teams interested in collaborating on a consortium to create a...

Considering COVID-19 vaccines and racial capitalism

In an article in June 2023 Dr Andreas Papamichail explores the importance of health policy in addressing “deep-rooted...

Africa needs vaccines to prevent “brewing” AMR pandemic

A review suggests that for Africa, a “high prevalence of infectious diseases" is combining with “weak healthcare systems...

Gavi celebrates immunisation of over 1 billion children

In June 2023 Gavi, the Vaccine Alliance, announced that it has contributed to efforts to vaccinate over 1...

Study: African vaccine confidence dip during the pandemic

A study in Human Vaccines and Immunotherapies in June 2023 found that confidence in vaccines declined across much...

CEPI and Celestial partner on self-adjuvanting mRNA platform

In June 2023 CEPI and Celestial Therapeutics announced a partnership to advance the development of Celestial’s “self-adjuvanting mRNA”...

TB project forms 19-strong consortium: TBVAC-HORIZON

Researchers at 19 institutions comprising the TBVAC-HORIZON have been awarded €9 million in funding to encourage research and...

Valneva publishes “detailed” chikungunya Phase III data

In June 2023 Valneva announced the publication of Phase III data for its single-shot chikungunya vaccine candidate VLA1553...

Mendus’ vididencel treatment increases cancer-killing cells

In June 2023 at the European Haematology Association Mendus presented new clinical data from the Phase II ADVANCE...

WHO South-East Asia calls for post-pandemic vaccine push

In June 2023 the WHO called for “focused efforts” from countries in the South-East Asia region to provide...

UK announces Biothreats Radar for biological risks

In June 2023 the Deputy Prime Minister of the UK, Oliver Dowden, announced that a new Biothreats Radar...

WHO and Global Fund commit to disease collaboration

In June 2023 the WHO and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund)...

Epigraph algorithm enables swine flu vaccine research

Researchers in Nebraska believe they are getting closer to an effective and potentially universal vaccine for swine flu...

Political economy study finds COVID-19 “imbalance”

During the COVID-19 pandemic the rate of technology acceleration was remarkable, and many communities across the globe were...

AI algorithms to support vaccine development for Disease X

In June 2023 CEPI and the Institute for Drug Discovery at Leipzig University announced a partnership to speed...

EU grant advances universal DeltaFLU vaccine development

A grant of €7.6 million from the EU will contribute to the efforts of a consortium of academic...

DRIVing vaccine innovation with Dr Sandeep Patel

Our next interview from the Congress last month was a recorded conversation with BARDA's Dr Sandeep Patel. Dr...

CEPI and aVaxziPen partner on vaccine delivery for access

CEPI and aVaxziPen Ltd announced in June 2023 that they are partnering to advance the development of two...

Moderna and Merck announce positive DMFS results from trial

In June 2023 Moderna and Merck, who have been collaborating on a Phase IIb study to evaluate mRNA-4157...

Novavax and Gates partner for adjuvant in vaccine research

Novavax announced in June 2023 that it has signed a three-year agreement with the Bill and Melinda Gates...

VaxEquity and CPI announce Innovate UK manufacturing grant

In June 2023 VaxEquity and CPI announced a grant of around £700k from Innovate UK, which will fund...

Transgene presents positive cancer vaccine data for HPV

French-based biotechnology company Transgene announced in June 2023 that new data confirm that its novel investigational therapeutic cancer...

Meeting unmet medical needs with Valneva’s Thomas Lingelbach

Next in our series of conversations with experts at the Congress last month is founding CEO of Valneva...

Strategies from a cross-sector workshop at WVC – Together we can achieve

Global disruptions to routine vaccination occurred during the COVID-19 pandemic setting vaccination programs back decades, risking future disease...

Planetary health meets public health: Dr Alex Dehgan

At the Congress in Washington last month we were lucky to meet Conservation X Labs CEO and co-founder...

Access through innovation: Dr Carmen Ledesma-Feliciano

Our next conversation from the Congress last month is an interview with PharmaJet's Dr Carmen Ledesma-Feliciano. Dr Ledesma-Feliciano...

Geo-diversification of vaccines: CEPI’s Dr Matthew Downham

Next in our interview series is CEPI's Dr Matthew Downham, who joined us at the Congress for a...

Diseases are “not done with us”, says Dr Ofer Levy

Our next interviewee is Dr Ofer Levy of Boston Children's Hospital; he joined us in Washington for several...

Animal diseases are “red flags” says Professor James Roth

As part of our series of conversations with experts at the Congress in Washington last month we were...

Agricultural equilibrium: old meets new with Joel Harris

Our next interview guest from the Congress last month is Genvax Technologies' CEO and Co-Founder, Joel Harris. Joel...

Dr Jules Millogo: “human beings want to do the right thing”

During the Congress last month we were lucky that Dr Jules Millogo made time to meet for a...

Galvanising the vaccine ecosystem: David Humphreys

Next up in our exclusive series of Congress interviews is this conversation with David Humphreys, Global Head of...

Conducting challenge trials: hVIVO’s Dr Andrew Catchpole

Our next guest is Dr Andrew Catchpole, hVIVO's Chief Scientific Officer, who joined us in Washington for the...

Universal influenza vaccine trial begins in the US

The clinical trial of an experimental universal influenza vaccine developed by researchers from the Vaccine Research Centre has...

Igniting Innovation in Vaccine Development: Early-stage Companies May Fuel the Future

Last month, I had the pleasure of attending the World Vaccine Congress—an experience that left me feeling inspired...

Africa innovating with the world: Professor Petro Terblanche

Next up in our series of Congress interviews is our conversation with Professor Petro Terblanche, CEO of Afrigen...

T cells and cancer immunosuppression: Dr Jay Berzofsky

Our next interview is with Dr Jay Berzofsky, Chief of the Vaccine Branch at NCI's Centre for Cancer...

“Vaccines are the great levelling field”, says Dr Nora Disis

At the World Vaccine Congress last month we were lucky to meet Dr Nora Disis of the University...

Mpox, like COVID-19, no longer a PHEIC says WHO

Just days after the COVID-19 pandemic was declared no longer a public health emergency of international concern (PHEIC)...

PDAC progress with personalised RNA neoantigen vaccines

An article in Nature in May 2023 presents work from a collaboration between Genentech, Memorial Sloan Kettering Cancer...

Challenging conventional thinking with Mei Mei Hu

In this interview we meet Mei Mei Hu, CEO and Co-Founder of Vaxxinity. She joined us at the...

Tilting the cancer battlefield with Dr Andrew Allen

At last month's Congress we were lucky to meet Dr Andrew Allen, CEO and Co-Founder of Gritstone Bio...

Driving public health conversations: Dr Jennifer McQuiston

Captain Dr Jennifer McQuiston joined us at the Congress last month to discuss the importance of animal vaccines...

NIH funds research into coronaviruses after 3-year pause

After the "termination and suspension” of a grant awarded in 2019, NIH and EcoHealth Alliance have announced a...

“Sentinels around the globe”: meeting the Integrum team

In 2018 Integrum Scientific was formed by a "group of global innovators" in response to "the need to...

“Trusted parents” encourage parents to vaccinate children

A study in Pediatrics in May 2023 explores the effects of different messaging angles on parents’ intentions to...

COVID-19 “established and ongoing” but no longer PHEIC

Committee members advised the WHO Director General that the pandemic is no longer a public health emergency of...

West Nile virus needs vaccines say health experts

In an article published in NEJM in May 2023 experts from the Division of Vector-Borne Diseases “revisit the...

UKHSA warns parents after increase in measles case

The UK Health Security Agency (UKHSA) published data in May 2023 that reveal a rise in measles cases...

A world first for GSK: US FDA approves RSV vaccine

In May 2023 the US FDA announced approval of Arexvy, the first respiratory syncytial virus vaccine to be...

VacTrack: “a digital solution”, says CEO Gabriella Hakim

Our next interview in the exclusive Congress series is our conversation with Gabriella Hakim of VacTrack. Gabriella is...

AI to design stable mRNA COVID-19 vaccine sequences

Research shared in Nature in May 2023 details work by a team from Baidu to develop an AI...

Breaking One Health barriers with Dr Jomana Musmar

As part of our exclusive interviews conducted at the World Vaccine Congress this month we are delighted to...

Transforming global access: UNICEF’s pooled procurement

Shortly after the publication of UNICEF’s State of the World’s Children report in April 2023, UNICEF explored the...

African vaccines in Ghana: a study in decolonisation

As became apparent during the COVID-19 pandemic, long-existing health inequalities mean that a location’s experience of public health...

Liverpool begins Phase I trial of Zika virus vaccine

The University of Liverpool announced in April 2023 that the first participant has received a dose of a...

Gavi’s ‘ZIP’: bringing vaccines to hard-to-reach children

Gavi announced in April 2023 that it is beginning a “push” to reach zero-dose children through a Zero-Dose...

Hitting HIV where it hurts: interview with Dr Gaurav Gaiha

Continuing our series of exclusive Congress interviews we are delighted to share a conversation with Dr Gaurav Gaiha...

World Malaria Day 2023: invest, innovate, implement

On 25th April 2023 the WHO observed World Malaria Day with a call for “increased implementation” of “new...

Ultimovacs trial delayed by slow disease progression

In April 2023 Ultimovacs ASA announced that it has adjusted guidance for communication of top-line data from early 2023...

Vaccine printer produces thermostable mRNA MNPs

An article in Nature Biotechnology explores the possibility presented through an automated process for printing microneedle patch (MNP)...

Cambridge begins needle-free vaccine trials for SARS-CoV-2

A team at the University of Cambridge and spin-out DIOSynVax has developed a vaccine to protect against SARS-CoV-2...

World Immunisation Week: “The Big Catch-Up” begins

As World Immunisation week (24-30 April) begins, we are exploring some of the WHO’s goals for the coming...

UKHSA concern over drop in adolescent vaccine uptake

UKHSA issued a press release and blog, coinciding with the start of World Immunisation Week, which suggested that...

Community engagement comes first for WHO expert

After an update from WHO in March 2023 on the Marburg virus situation in Equatorial Guinea and Tanzania...

Gut instinct: microbial parameters and immune variations

A study published in Nature communications biology identifies “several factors associated with COVID-19 vaccine-induced adaptive immune responses”...

UNICEF’s ‘state of the world’ immunisation warning

In April 2023 UNICEF published its The State of the World’s Children report with a focus on the...

mRNA Technology Transfer Programme progresses

In April 2023 the participants of the mRNA Technology Transfer Programme met for their first face-to-face meeting in...

Allergy Therapeutics continues with peanut allergy study

Allergy Therapeutics announced that patients with peanut allergies had “successfully” taken the “innovative short-course peanut allergy vaccine candidate”...

PharmaJet announces expansion and extension with DTRA

In April 2023 PharmaJet announced that it had received a “scope expansion” and “3-year extension” of a multi-year...

Better pandemic preparedness: WHO launches PRET

WHO announced in 2023 that it was launching a new initiative to equip countries with the “systems and...

MinervaX starts Phase I GBS trial in older adults

MinervaX announced in April 2023 that it is beginning a Phase I clinical study of its novel Group...

The Vaccination Trust Indicator (VTI) in validation study

A study in PLOS Global Public Health in April 2023 presents a validation of the Vaccination Trust Indicator...

ChAdOx1 vaccine for Rift Valley fever shows promise in trial

In a paper published in The Lancet Infectious Diseases, researchers detailed the results of a trial for a...

EPSRC invests £12m in Future Vaccines Manufacturing Hub

The Engineering and Physical Sciences Research Council (EPSRC) announced a £12 million investment to fund the Future Vaccines...

Ghana approves “world-changer” malaria vaccine for children

In April 2023 it was reported that Ghana is the first country to approve a new malaria vaccine...

UK researchers assesses TBEV risk to population as low

UKHSA issued a press release explaining the risk assessment produced by HAIRS on the risk presented to the...

“Time is of essence” in outbreaks says Dr Jane Ruth Aceng

In an interview between Africa CDC and the Minister for Health in the Republic of Uganda, Dr Aceng...

Moderna granted PRIME designation by EMA for therapy

Moderna announced in April 2023 that the mRNA-4157/V940 has been awarded Priority Medicines (PRIME) scheme designation by the...

GlobalData warning follows WHO COVID-19 vaccine update

After WHO revised vaccine guidance following a SAGE meeting, GlobalData issued a statement warning about the effects on...

Exclusive interview with Dr Fadil Bidmos

As the countdown to the World Vaccine Congress in Washington continues with only days to go, we are...

A better vaccine ecosystem: what does the future hold?

After experts called for “transformational change” to the “epidemic countermeasures ecosystem”, our interest has been drawn to The Vaccine...

SAGE revises roadmap for COVID-19 vaccination use

After a meeting in March 2023, WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) revised the roadmap...

Study explores COVID-19 vaccine fatigue determinants

A study published in Nature Medicine in March explores the factors associated with so-called “vaccine fatigue”, with a...

Quadripartite calls for One Health action for “safer world”

In March 2023 the heads of the Quadripartite organisations working on One Health issued a call for greater...

CDC warns of “alarming” threat from Candida auris

In March 2023 the CDC commented on data that revealed an “alarming” spread of the emerging fungus Candida...

COVID-19 vaccine not linked to menstruation changes in study

A study released in iScience suggests that COVID-19 infection was a greater factor than COVID-19 vaccination in observed changes...

The politics of pandemics: WHO questions data secrecy

After we reported in March 2023 that possibly critical data concerning the Huanan Seafood Wholesale Market had been...

WHO offers update on Marburg cases in Equatorial Guinea

Just under a month after the confirmation of an outbreak of Marburg virus disease (MVD) in Equatorial Guinea...

Universal oral COVID-19 vaccine protects hamsters in study

A study in Microbiology Spectrum in March 2023 demonstrated the benefits of an oral vaccine for COVID-19 that...

Marking World TB Day 2023: “Yes! We can end TB!”

On Friday 24th March 2023 the WHO and other organisations and individuals observe ‘World Tuberculosis Day’ with the...

Vaccine equity as good as it sounds, study suggests

In a study published in Nature Communications, researchers investigate the socioeconomic benefits of a set of “idealised” vaccine...

China accepts first mRNA vaccine for COVID-19 from CSPC

In March 2023 the board of directors at CSPC Pharmaceutical Group Limited announced that the company’s COVID-19 mRNA...

Africa CDC confirms outbreak of Marburg virus in Tanzania

Africa CDC has confirmed that the Ministry of Health of the Republic of Tanzania declared an outbreak of...

Vaxxinity starts trial of LDL cholesterol vaccine candidate

Vaxxinity announced that the first subjects of a Phase I trial had been dosed. The trial of VXX-401...

Vaccitech announces “promising” data for HPV vaccine

In March 2023, Vaccitech announced top-line interim data from a Phase Ib/II clinical trial of its VTP-200 vaccine...

SpyBiotech granted funding for SpyVector platform project

SpyBiotech, a biotechnology company spin out from the University of Oxford, announced in March 2023 that it had...

Exclusive interview with Dr Niranjan Sardesai

With just weeks to go until the World Vaccine Congress in Washington, we are delighted to share our...

RVAC and Penn collaborate on possible mRNA therapies

In March 2023, RVAC Medicines and the University of Pennsylvania (Penn) announced a collaboration to pursue the development...

WHO weighs in on new SARS-CoV-2 data from China

In March 2023 new metagenomics data and SARS-CoV-2 sequences appeared on GISAID and were available to researchers across...

Vaccine-derived polio: Burundi and DRC start investigations

The Global Polio Eradication Initiative (GPEI) and WHO Africa confirmed that cases of circulating vaccine-derived poliovirus type 2...

A GBS vaccine could save lives and money, say researchers

A study published in PLOS Medicine in March 2023 suggests that the human and financial benefits of a...

Uganda’s plan to vaccinate children against yellow fever

In March 2023 WHO Africa reported that the Ugandan Ministry of Health is planning to vaccinate over 1.9...

LG Chem wins bid to supply essential vaccines for children

South Korean chemical company LG Chem announced in March 2023 that it will supply essential vaccines for infants...

GSK’s 5-in-1 Meningococcal vaccine shows promise in trial

In March 2023 GSK announced positive headline results from a Phase III trial evaluating its MenABCWY combination vaccine...

Experts call for change in the epidemic ecosystem

Writing in The Lancet in March 2023, public health experts called for “ambitious, transformational change” to the “epidemic...

Exclusive interview with Dr Ike James

With just weeks to go until the World Vaccine Congress in Washington this April, we are delighted to...

Thermostable tuberculosis vaccine meets Phase I goals

Tuberculosis is one of the leading infectious causes of morbidity and mortality across the world. In 2020 it...

Study suggests sleep key to successful vaccine responses

A study published in Current Biology suggests that getting sufficient sleep in the days surrounding vaccination is key...

VIE awards 2023: the final shortlist announced!

We are pleased to share the organisations and individuals who have progressed to the final shortlist for the...

Researchers in Israel develop mRNA vaccine against bacteria

Researchers at Tel Aviv University and the Israel Institute for Biological Research announced that they have developed an...

Will cell-free processes accelerate vaccine development?

Carrie Arnold explores cell-free processes and a “growing number of biomanufacturing firms” that are “embracing” a cell-free biosynthesis...

Lassa vaccine in monkeys: protection not therapy

Researchers in France published a paper in Nature Communications in March detailing the results of an investigation into...

Exclusive interview with Dr Yongjun Sui

As we continue our countdown to the World Vaccine Congress in Washington we are delighted to share conversations...

GSK “delighted” by VRBPAC vote on RSV candidate

Just after Pfizer announced that the Vaccines and Related Biological Products Advisory Committee had voted on its RSV...

Pfizer “encouraged” by VRBPAC vote on RSV candidate

In 2023, a few days after the FDA requested further studies into the link between GBS and its...

Exclusive interview with Dr Mark Feinberg

With just two months until the World Vaccine Congress we are delighted that some of our wonderful speakers...

WHO issues update on avian flu in Cambodia

After the news of the death of a child from avian influenza A (H5N1) in Cambodia in February...

Ghana confirms two cases of Lassa fever in Accra

Just months after the conclusion of an outbreak of Marburg, the Ghana Health Service has issued a statement...

WHO issues update on Marburg in Equatorial Guinea

Following the announcement of an outbreak of Marburg virus in Equatorial Guinea in February 2023, WHO has issued a...

FDA requests research into Pfizer’s RSV GBS risk

Following the FDA’s acceptance for review for Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, the agency has asked...

Queensland’s quest for an Australian cattle vaccine

Researchers at the University of Queensland are pursuing an experimental vaccine to tackle a venereal disease that “causes...

Maternal vaccination information in New Zealand

A study in Midwifery in February 2023 examines the quality of maternal vaccination information available in pregnancy to...

Concern after avian influenza kills child in Cambodia

With growing concern at the increasing cases of avian influenza in mammals across the world, the spread has...

The Measles and Rubella Initiative enters “new era”

After an update from WHO in November 2022 that almost 40 million children are “dangerously susceptible” to measles...

LinKinVax welcomes HIV candidate Phase I results

In February 2023 LinKinVax announced positive interim results from the ANRS VRI06 Phase I trial, evaluating a preventative...

Moderna and Merck granted BTD for cancer therapy

Following positive results from a Phase IIb trial in December 2022, Moderna and Merck have announced that their...

When pigs fly – or vaccinate themselves against Salmonella

The complex process of vaccinating pigs is time consuming and requires direct interaction between humans and animals, or...

Funding Australian efforts for mRNA Strep A vaccine

The University of Queensland, Australia, announced in February 2023 that a university-led research effort had secured almost $8...

Synthetic squalene: a sustainable alternative to shark?

An article in npj vaccine in February 2023 explores the role of squalene in vaccine development and how...

African leaders unite on routine immunisation goals

In February 2023, at a meeting of the African Union in Addis Ababa, African Heads of State agreed...

World Vaccine Congress Washington: meet our start-ups!

As we get closer to the World Vaccine Congress in Washington our introductions to the start-up zone continue!...

Montenegro’s “Health Caravan” promotes immunisation

In February 2023 WHO announced a collaboration with Montenegro’s Ministry of Health and Institute of Public Health (IPH)...

BactiVac secures £1 million in Wellcome funding

BactiVac, the Bacterial Vaccines Network, announced it had secured £1 million in funding from Wellcome to “accelerate the...

Scancell announces “encouraging” early Modi-1 data

In February 2023 Scancell announced completion of a monotherapy dose finding arm of the Phase I/II ModiFY clinical...

Dr Jean Kaseya appointed Director General of Africa CDC

Dr Jean Kaseya was announced the new Director General of Africa CDC at the African Union summit in...

French study explores vaccination and housing situation

A paper published in February 2023 examines the results of a study investigating how a person’s housing situation...

Pfizer and Valneva issue update on Lyme vaccine trial

Pfizer, study sponsor of the VALOR Phase III clinical study, has decided to “discontinue a significant percentage of...

US researchers develop platform for viral pathogens

Harvard T.H. Chan School of Public Health announced a new and “highly adaptable” vaccine platform with potential applications...

Exclusive interview with the US BIOLOGIC team

Next up in our series of interviews in preparation for the Congress are our speakers from US BIOLOGIC:...

Moderna announces “mixed” interim flu results

In February 2023 Moderna announced interim results from its Phase III safety and immunogenicity trial of mRNA-1010 (P301)...

CEPI supports Sudan ebolavirus antibody standard

CEPI announced that it was supporting development of an international antibody standard against Sudan ebolavirus (SUDV) following the...

Mpox: still a PHEIC, says IHR Emergency Committee

During a meeting of the IHR Emergency Committee in February 2023 on the mpox outbreak, the current infection...

Gritstone bio and NCI collaborate on clinical trial

Gritstone bio and NCI announce a collaboration to evaluate an “autologous T cell therapy expressing a T cell...

VBI Vaccines announces Phase II data for HBV therapy

In February 2023 VBI Vaccines announced interim data evaluating a combination treatment of VBI-2601 and BRII-835 in chronically...

WHO responds to Nature “error in reporting” article

After it was suggested that WHO had abandoned plans to continue the investigation into the origins of COVID-19...

One Health approaches: the agricultural perspective

In our discussions at the World Vaccine Congress and in published posts we continue to explore the meaning...

Nature: WHO investigation into pandemic origin dropped

WHO has “quietly shelved the second phase” of the “much-anticipated scientific investigation” into the origins of the COVID-19...

Bavarian Nordic announces Emergent travel vaccine agreement

In February 2023 Bavarian Nordic announced that it has entered into an agreement with Emergent BioSolutions to acquire...

World Vaccine Congress Washington: meet our start-ups!

With just 7 weeks until the World Vaccine Congress in Washington in April we are still announcing the...

Vaxart announces start of Phase II norovirus trial

In February 2023 Vaxart announced that it had dosed its first subject in the Phase II clinical trial...

US and Novavax announce modified COVID-19 agreement

In February 2023 Novavax and the US Department of Health and Human Services (HHS) announced a modification to...

Equatorial Guinea confirms outbreak of Marburg virus

In February 2023, WHO Africa confirmed that Equatorial Guinea had announced an outbreak of Marburg virus disease following...

Gavi appoints Dr Muhammad Ali Pate as CEO

In February 2023 Gavi announced the conclusion of a process that had begun in 2021: appointing a CEO...

Health inequity or vaccine hesitancy: understanding barriers

A report in Nature Human Behaviour in February 2023 examines reporting oversights in examining the factors behind vaccine...

New diagnostic test identifies virus types and strains

Researchers from the University of Oxford announced in February 2023 that they had developed a new diagnostic test...

SK bioscience launches R&PD Centre for global health

In February 2023 SK bioscience announced its intention to establish the ‘Songdo Global Research & Process Development Centre...

Challenges and opportunities of VLP-based vaccines

In a paper published in Frontiers in Immunology in February 2023, researchers review the challenges associated with the...

Concern grows as avian flu affects more mammals

With reports of avian flu sweeping through other mammals across the world, concern is growing about the threat...

Maternal Tdap vaccine reduces pertussis in infants

In findings published in Jama Pediatrics in February 2023 a CDC study revealed that the maternal Tdap vaccine...

Exclusive interview with Dr Francesca Micoli

With just under 10 weeks to go until the World Vaccine Congress in Washington we are already getting...

UNEP report “Bracing for Superbugs”: AMR and One Health

The United Nations Environment Programme released a report in 2023 that addresses the role of the environment in...

Gerresheimer and Corning partner on Velocity Vials

Gerresheimer AG and Corning Incorporated announced in February 2023 that they were collaborating to “increase global access to...

Africa CDC hosts Biomanufacturing Workforce workshop

Between 7th and 9th February 2023 30 partner organisations came together to participate in the first Biomanufacturing Workforce Development...

UK MHRA grants Takeda authorisation for Dengue vaccine

In February 2023 Takeda UK Ltd. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) had...

World Vaccine Congress Washington: meet our start-ups!

As excitement builds for the World Vaccine Congress in Washington this April we are pleased to share a...

mRNA sights shift to universal flu potential

Professor Deborah Fuller, writing for The Conversation in February 2023, states that “for everything there is a season...

Pharma companies ride the economic wave of 2022

In research from GlobalData in December 2022, 13 of the top 20 pharmaceutical companies saw increases in market...

The Pandemic Fund invites submissions for projects

In February 2023 the World Bank Pandemic Fund announced $300 million for a first round of funding to...

UK announces progress on bovine TB vaccine and test

In February 2023 the UK Animal and Plant Health Agency (APHA) announced that field trials for a cattle...

NIH researchers develop promising SUDV vaccine

Research in The Lancet Microbe in February 2023 presents a positive update from an NIH group with their...

Exclusive interview with Dr Ofer Levy last year

As we continue preparations for the World Vaccine Congress in Washington this April we are delighted to share...

Bird flu affecting otters and foxes in the UK

After reports of an outbreak of HPAI in minks from a farm in Spain, updates from the UK...

CEPI to support 20Med mRNA vaccine technology

In February 2023 CEPI announced a partnership with 20Med to advance the development of 20Med’s bioresponsive polymeric nanoparticle...

African leaders vow to end AIDS in children by 2030

At the first ministerial meeting of the Global Alliance to end AIDS in children, leaders from African countries...

IVAC runs vaccine hesitancy training course in India

In December 2022 the International Vaccine Access Centre was able to conduct a test run of its newly...

The 100 days mission: UKHSA assumes responsibility

Of the many lessons that we are endeavouring to learn from the COVID-19 pandemic, the importance of uniting...

Cancer vaccines strengthened against aggressive tumours

In research published in Nature biomedical engineering a team of scientists at Northwestern University’s IIN explored the effects...

World Vaccine Congress Washington: meet our start-ups!

Following our previous posts, moving through the start-up zone at the World Vaccine Congress in Washington at speed...

Moderna secures FDA Breakthrough Therapy Designation for RSV

Moderna announced in January 2023 that its investigational mRNA vaccine candidate for RSV, mRNA-1345, has been granted Breakthrough...

White paper from IAVI: vaccine partnerships for EIDs

In January 2023 IAVI released a white paper after a meeting between global health experts.  As a result...

Marburg vaccine candidate shows in-human promise

A study in The Lancet with NIH funding reported that a vaccine candidate against Marburg virus (MARV) was...

WHO in January 2023: COVID-19 still a PHEIC

The 14th meeting of the International Health Regulations (IHR) Emergency Committee regarding COVID-19 took place on Friday 27th...